Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia van der Hoven

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The American Journal of Pathology|May 7, 2020
Neurodegeneration and Motor Deficits in the Absence of Astrogliosis upon Transgenic Mutant TDP-43 Expression in Mature MiceGabriella Chan, Annika van Hummel, Julia van der Hoven, et al.
Scientific Reports|September 26, 2018
Neuronal MAP kinase p38α inhibits c-Jun N-terminal kinase to modulate anxiety-related behaviourKristie Stefanoska, Josefine Bertz, Alexander M Volkerling, et al.
Science Advances|December 2, 2022
Treatment of epilepsy using a targeted p38γ kinase gene therapyNicolle Morey, Magdalena Przybyla, Julia van der Hoven, et al.
International Journal of Pharmaceutics|February 24, 2024
An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targetingChun Yuen Jerry Wong, Alberto Baldelli, Ole Tietz, et al.
Neuropathology and Applied Neurobiology|March 23, 2023
TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse modelsAnnika van Hummel, Miheer Sabale, Magdalena Przybyla, et al.
International Journal of Alzheimer'S Disease|June 22, 2012
Lessons from tau-deficient miceYazi D Ke, Alexandra K Suchowerska, Julia van der Hoven, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Engineering a Novel Bacterial Encapsulin for Programmable Surface Functionalization: From Single-Target to Mosaic NanovaccinesIndia Boyton, Claire Rennie, Julia van der Hoven, et al.
RSC Advances|October 31, 2024
Design of peptide therapeutics as protein-protein interaction inhibitors to treat neurodegenerative diseasesDaryl Ariawan, Kanishka P M Thananthirige, Ali El-Omar, et al.
Scientific Reports|August 16, 2020
Contribution of endogenous antibodies to learning deficits and astrocytosis in human P301S mutant tau transgenic miceJulia van der Hoven, Annika van Hummel, Magdalena Przybyla, et al.
Plos One|October 14, 2016
No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin MiceAnnika van Hummel, Mian Bi, Stefania Ippati, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The American Journal of Pathology|May 7, 2020
Neurodegeneration and Motor Deficits in the Absence of Astrogliosis upon Transgenic Mutant TDP-43 Expression in Mature MiceGabriella Chan, Annika van Hummel, Julia van der Hoven, et al.
Scientific Reports|September 26, 2018
Neuronal MAP kinase p38α inhibits c-Jun N-terminal kinase to modulate anxiety-related behaviourKristie Stefanoska, Josefine Bertz, Alexander M Volkerling, et al.
Science Advances|December 2, 2022
Treatment of epilepsy using a targeted p38γ kinase gene therapyNicolle Morey, Magdalena Przybyla, Julia van der Hoven, et al.
International Journal of Pharmaceutics|February 24, 2024
An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targetingChun Yuen Jerry Wong, Alberto Baldelli, Ole Tietz, et al.
Neuropathology and Applied Neurobiology|March 23, 2023
TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse modelsAnnika van Hummel, Miheer Sabale, Magdalena Przybyla, et al.
International Journal of Alzheimer'S Disease|June 22, 2012
Lessons from tau-deficient miceYazi D Ke, Alexandra K Suchowerska, Julia van der Hoven, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2026
Engineering a Novel Bacterial Encapsulin for Programmable Surface Functionalization: From Single-Target to Mosaic NanovaccinesIndia Boyton, Claire Rennie, Julia van der Hoven, et al.
RSC Advances|October 31, 2024
Design of peptide therapeutics as protein-protein interaction inhibitors to treat neurodegenerative diseasesDaryl Ariawan, Kanishka P M Thananthirige, Ali El-Omar, et al.
Scientific Reports|August 16, 2020
Contribution of endogenous antibodies to learning deficits and astrocytosis in human P301S mutant tau transgenic miceJulia van der Hoven, Annika van Hummel, Magdalena Przybyla, et al.
Plos One|October 14, 2016
No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin MiceAnnika van Hummel, Mian Bi, Stefania Ippati, et al.
Pageof 3